Haase, Max A. B. https://orcid.org/0000-0002-8962-0446
Lazar-Stefanita, Luciana https://orcid.org/0000-0003-2388-9757
Baudry, Lyam https://orcid.org/0000-0002-9283-674X
Wudzinska, Aleksandra
Zhou, Xiaofan https://orcid.org/0000-0002-2879-6317
Rokas, Antonis https://orcid.org/0000-0002-7248-6551
Hittinger, Chris Todd https://orcid.org/0000-0001-5088-7461
Pfander, Boris
Musacchio, Andrea https://orcid.org/0000-0003-2362-8784
Boeke, Jef D. https://orcid.org/0000-0001-5322-4946
Article History
Received: 12 April 2025
Accepted: 23 December 2025
First Online: 18 February 2026
Competing interests
: J.D.B. is a founder and director of CDI Labs, Inc., a founder of and consultant to Opentrons LabWorks/Neochromosome, Inc., a founder of JATech LLC and serves or served on the Scientific Advisory Board of CZ Biohub New York, LLC, Logomix, Inc., Rome Therapeutics, Inc., SeaHub, Seattle, WA, Tessera Therapeutics, Inc. and the Wyss Institute. A.R. is a scientific consultant for LifeMine Therapeutics, Inc. All these activities are unrelated to this work. The other authors declare no competing interests.